Similar articles

• The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.

  Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, Musick B, Sidle J, Yiannoutsos C, Ayaya S, Carter EJ. Braitstein P, et al. Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5. Pediatr Infect Dis J. 2009. PMID: 19451858
• The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.

  Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. Frigati LJ, et al. Thorax. 2011 Jun;66(6):496-501. doi: 10.1136/thx.2010.156752. Epub 2011 Apr 2. Thorax. 2011. PMID: 21460373 Clinical Trial.
• HIV-associated tuberculosis: diagnostic and treatment challenges.

  El-Sadr WM, Tsiouris SJ. El-Sadr WM, et al. Semin Respir Crit Care Med. 2008 Oct;29(5):525-31. doi: 10.1055/s-0028-1085703. Epub 2008 Sep 22. Semin Respir Crit Care Med. 2008. PMID: 18810685 Review.
• Tuberculosis in HIV-infected patients: a comprehensive review.

  Aaron L, Saadoun D, Calatroni I, Launay O, Mémain N, Vincent V, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O. Aaron L, et al. Clin Microbiol Infect. 2004 May;10(5):388-98. doi: 10.1111/j.1469-0691.2004.00758.x. Clin Microbiol Infect. 2004. PMID: 15113314 Review.
• Impact of a public antiretroviral program on TB/HIV mortality: Banteay Meanchey, Cambodia.

  Eng B, Cain KP, Nong K, Chhum V, Sin E, Roeun S, Kim S, Keo S, Heller TA, Varma JK. Eng B, et al. Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):89-92. Southeast Asian J Trop Med Public Health. 2009. PMID: 19323039